Conclusions Ultimately, the current maintenance dose of 1,000 mcg B12 every 3 months may confer long term harm, therefore it seems that once B12 levels are stabilised well within acceptable range, then the standard B12 intervention of 1000 mcg should be administered annually, and monitored with pre-injection annual testing of levels
John David Henneberry-Fudge, MD, FRCPC
They sit in this interesting middle zone between nutrition and pharmaceuticals
In research contexts, cagrilintide is mainly studied for its ability to: Activate amylin receptor pathways Interact with calcitonin receptor-related systems Influence satiety and food intake signaling Support metabolic and endocrine communication research Contribute to studies involving body-weight and energy-balance models This makes cagrilintide especially relevant in research focused on obesity, metabolic dysfunction, appetite regulation, and multi-hormone peptide activity
How to communicate risks involved in management